Insight

Ravi Majeti: How AAV templates used in Cas9 genome engineering form concatemeric insertions

Photo from Majeti Lab/X

Apr 13, 2024, 11:09

Ravi Majeti: How AAV templates used in Cas9 genome engineering form concatemeric insertions

Ravi Majeti, Director of the Institute for Stem Cell Biology and Regenerative Medicine at the , shared on their X/Twitter:

”In work by Fabian Suchy and Daiki Karigane, we demonstrate how AAV templates used in Cas9 genome engineering form concatemeric insertions and describe mitigation strategies. Great collaboration with Hiro Nakauchi’s lab, published today in Nature Biotechnology.”

Source: Majeti Lab/X

AAV templates cancer Cas9 genome Daiki Karigane Fabian Suchy Hiro Nakauchi's lab Majeti Lab mitigation strategies Nature Biotechnology OncoDaily Oncology Ravi Majeti Stanford University School of Medicine

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage